.jpg%3Ftrim%3D0%2C0%2C0%2C0%26width%3D1200%26height%3D800%26crop%3D1200%3A800&w=3840&q=100)
Kelly Clarkson's ex-husband Brandon Blackstock's cause of death revealed
Read more Support Now
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it. Your support makes all the difference.
Read more
Kelly Clarkson's ex-husband, Brandon Blackstock's, cause of death has been revealed.
Blackstock — who shared two children with Clarkson — died Thursday at the age of 48, three years after he was diagnosed with cancer.
Silver Bow County Coroner Dan Hollis confirmed to People Monday that his cause of death was melanoma, a form of skin cancer. The manner of his death was natural causes.
'Brandon Blackstock passed away peacefully at his home in Butte, Montana, on August 7 under hospice care surrounded by his family,' Silver Bow County Coroner Dan Hollis said.
According to the Mayo Clinic, the first signs of melanoma are a change in an existing mole on your skin or 'the development of a new pigmented or unusual-looking growth on the skin.' Melanoma symptoms 'most often develop in areas that have had exposure to the sun,' including arms, back, face and legs.
open image in gallery Brandon Blackstock died at the age of 48 on August 7. Now, Kelly Clarkson's former husband's cause of death has been revealed.
( Getty )
A representative for Blackstock confirmed his death in a statement to People last week.
'It is with great sadness that we share the news that Brandon Blackstock has passed away,' the statement reads. 'Brandon bravely battled cancer for more than three years. He passed away peacefully and was surrounded by family. We thank you for your thoughts and prayers and ask everyone to respect the family's privacy during this very difficult time.'
Blackstock was a talent manager and a former stepson of country star Reba McEntire. He and Clarkson were married from 2013 to 2022 and have two children together, River, 11, and Remington, nine.
Clarkson has not publicly spoken out about her ex-husband's death.
News of Blackstock's death also came hours after Clarkson postponed the remainder of her Las Vegas residency dates for August.
'Unfortunately, I need to postpone the remainder of the August Studio Session dates in Las Vegas,' the singer wrote in an Instagram post at the time. 'While I normally keep my personal life private, this past year, my children's father has been ill and at this moment, I need to be fully present for them.'
'I am sincerely sorry to everyone who bought tickets to the shows and I so appreciate your grace, kindness and understanding.'
open image in gallery He and Clarkson were married from 2013 to 2022 and have two children together, River, 11, and Remington, nine
( Getty Images for NARAS )
Blackstock and Clarkson finalized their divorce in 2022, with the singer agreeing to give a one-time payment of $1.3 million to her ex-husband, along with monthly child support in the amount of $45,601.
The 'Stronger' singer has also spoken candidly about ending the relationship in 2020, after nearly seven years of marriage. During an appearance on the We Can Do Hard Things with Glennon Doyle podcast in 2023, she explained why she ultimately convinced herself to stay with Blackstock for as long as she did.
'I was like, 'I can do this. I can handle so much,'' she said. 'My ego is, 'I can control my actions, I can control my reactions, I can do this and I can reach this person and I can get through.' It becomes a little bit of your ego that gets in the way.'
Last month, Clarkson had to postpone her opening night show at The Colosseum at Caesars Palace just hours before she was set to take the stage for health reasons.
'We have been working 24/7 to make Studio Sessions the most intimate and extraordinary experience with and for my incredible fans,' she said on Instagram at the time. 'I am beyond grateful that you always show up for me and I am devastated to have to postpone tonight and tomorrow's opening at Caesars.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medical News Today
26 minutes ago
- Medical News Today
GLP-1 microdosing for weight loss: Experts weigh the pros and cons
Over the last few years, the popularity of taking GLP-1 medications for weight loss has greatly increased. More than half of Americans taking GLP-1s say it was difficult to afford. Online health platform Noom recently launched its Noom Microdose GLP-1Rx Program to reportedly address barriers to GLP-1s, including medication cost. Over the last few years, the popularity of glucagon-like peptide-1 receptor agonists (GLP-1) used for weight loss has greatly increased. Type 2 diabetes medications like Ozempic and Mounjaro are sometimes prescribed off label for weight loss, while Wegovy and Zepbound are approved for the treatment of obesity. Industry researchers estimate that while about 12% of United States citizens have used a GLP-1 medication for weight loss, 54% of adults who have taken GLP-1s say it was difficult to afford, and 53% say it was still too expensive even if they received insurance coverage for the medication. Medication cost is just one of the reasons why online health platform Noom recently launched its Noom Microdose GLP-1Rx Program, which, according to the company, also helps lower potential side effects and helps with creating sustainable behavior changes. Medical News Today spoke with five GLP-1 medical experts to find out what exactly is microdosing and how it is different from taking normal amounts of GLP-1 medications, as well as its safety and efficacy. What is microdosing? According to Maria Cecilia C. Asnis, MD, FACE, DABOM, director of The Center for Weight Management at Stamford Health and assistant clinical professor of medicine at Columbia University Vagelos College of Physicians and Surgeons, GLP-1 microdosing is the new 'buzzy' term circulating in the conversation regarding these tools for weight management.'However, the concept of flexibility in dosing and personalization of medication management is not new in the clinical space,' Asnis explained to MNT. 'Every individual person has unique needs and goals — and the 'dose' they need to achieve and maintain those goals is also unique. In that same vein, the dose people respond to and tolerate without side effects is also individual.' Babak Orandi, MD, PhD, obesity medicine specialist and transplant surgeon at the NYU Langone Weight Management Program, and associate professor in the Departments of Surgery and Medicine at NYU Grossman School of Medicine, said that for many doctors who prescribe this class of medications frequently, microdosing is something they have already been trying. 'When I counsel my patients, I tell them that the study sponsors have to escalate the dose monthly in clinical trials but that doesn't mean I have to practice medicine that way,' Orandi explained to MNT. 'Some patients are more responsive to lower doses than others and pushing them to a dose faster or higher than is necessary just leads to side effects.' Similarly, Kayley George, MS, RD, LD, a registered dietitian, and founder of the Ditch the Diet coaching program,told MNT that microdosing through Noom or any other platform is not necessarily different from what doctors prescribe with, for example, Ozempic — the active ingredient, semaglutide, is still the same. 'What Noom is offering, however, is a lower dose than the traditional FDA-approved dosing regimen,' George explained. 'The traditional Ozempic dosing starts at 0.25 mg [milligrams] once weekly and is escalated typically every four weeks. In contrast, Noom states that their dosing starts at 25% or less of the standard 0.25 mg dose and escalates at a personalized rate.'Is microdosing GLP-1s safe? While microdosing GLP-1 medications may provide a more personalized experience, there are still questions regarding the safety of this practice as there are currently no published studies on the process, and the microdoses may come from a compounding pharmacy. Jennifer Cheng, DO, chief of endocrinology at Hackensack Meridian Jersey Shore University Medical Center in New Jersey, told MNT that, right now, GLP-1 microdosing is an experimental means that is not well studied currently, there is no reliable information on the safety and side effects of microdosing GLP-1, and there are no guidelines on how microdosing should occur.'Safety is unknown; [it remains] unknown if [this approach] is good or bad,' Cheng continued. 'It still may trigger the side effects of GLP-1. Giving a smaller dose of Ozempic or any other GLP-1 can still produce these side effects such as nausea, vomiting, muscle loss, upset stomach, headaches, and slowing of bowel movements potentially leading to ileus or obstruction.' George said that microdoses of the drug are only as safe as the pharmacy producing it:'To access these custom doses, Noom must use a specialized compounding pharmacy. 'Their website claims to work with a 'leading 503B FDA-inspected pharmacy to dispense compounded semaglutide medication.' They also highlight that the compounding pharmacies are U.S. Pharmacopeia (USP)-compliant.' 'Although they've taken extensive measures to ensure safety, it's still important to understand that compounded medications are not FDA-approved,' she continued. 'This means the final product is not reviewed for safety or efficacy the way commercial drugs are. In addition, compounded medications are typically not covered by insurance.' How effective is GLP-1 microdosing? Mir Ali, MD, a board-certified general surgeon, bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, told MNT that while it is usually not harmful to microdose GLP-1 medications, they may be less effective.'Though some patients may feel the effect of these medications at lower doses, most patients require a higher dose to see significant results,' Ali explained. 'It may be useful in patients who have achieved their goal weight and are using lower doses to maintain their weight.' However, 'early data and clinical experience suggest that it is an effective strategy,' Orandi commented. 'People with diabetes, particularly severe diabetes, tend to lose less weight with GLP-1s than people without diabetes, so microdosing is less likely to be as effective, though their dose should only be increased as they tolerate it.' George said that in her professional opinion, microdosing is a potential option for patients with smaller amounts of weight to lose or as a bridge to start, or wean off, regular GLP-1 medications.'It may also be used as a maintenance dose after significant weight loss has already been achieved,' she added. 'I would not recommend microdosing GLP-1s for individuals with significant amounts of weight to lose or known metabolic dysregulation.' Is GLP-1 microdosing right for me? The bottom line is that there are still questions regarding the effectiveness and safety of microdosing GLP-1 medications, and this type of regimen is not for everyone. 'I would like people to know that microdosing is not the normal way these medications are used, though it may be feasible in those who have achieved the desired results or have much less weight to lose,' Ali to George:'Microdosing is a big trend in the weight management space but still not FDA-approved. Noom hit the nail on the head — patients need access to more affordable versions of GLP-1 medications with more tolerable side effects. As more generic, low-cost versions of Ozempic become available and medication innovations improve, I believe we'll see more solutions rolled out in the near future. Compounded microdosing is a good interim solution, but patients considering this option need to be very cautious on where the medication is sourced.'Experts also stressed the importance of having medical oversight while using GLP-1 medications. 'It is essential that people be medically evaluated and followed on these medications in the long term — not just when they are paying to subscribe to a program,' Asnis said. 'In the end, if we can increase access to these tools while maintaining oversight, and put patient outcomes over profits, that is what will ultimately move the needle on the proverbial scale in the pandemic of excess weight.' And Cheng noted that: 'It is better to use FDA approved treatments rather than experimental and unproven treatments.'Moreover, 'it is important to speak with your healthcare professional regarding the use of GLP-1 or microdosing,' he emphasized. 'There are risks, benefits and possible side effects to medications and, if discussed, they can help you navigate through the possible effects.' Finally, Orandi offered strategies to help minimize side effects that people should follow when taking GLP-1 medications in general. 'Eat slowly,' he advised. 'Avoid heavy, fatty foods, particularly in the first 24–48 hours of the injection. [And] don't force yourself to eat when you're not hungry.'


Telegraph
2 hours ago
- Telegraph
Baby FGM death in the Gambia ‘should shame us all'
A one month old child has died after being subjected to female genital mutilation (FGM), reigniting anger and concern about the practice across the region. The infant reportedly died from severe bleeding after undergoing FGM in the West African country of The Gambia. Nimco Ali, a former Home Office advisor on violence against women and the CEO of the Five Foundation, a grassroots organisation tackling FGM, said the baby's death 'should shame us all'. 'She deserved so much more from us, and from an international community that boasts of caring for women and girls,' she told The Telegraph. FGM involves the deliberate cutting or removal of external female genitalia in the name of preserving so-called 'purity' and 'virginity'. Two women have been arrested for their alleged involvement, local police said. 'This is violence, pure and simple' The death of such a young girl has sparked widespread outrage in the tiny West African country, which officially banned FGM in 2015. Women In Leadership and Liberation, an organisation which works to protect the rights of women and girls in The Gambia, said: 'Culture is no excuse, tradition is no shield, this is violence, pure and simple.' Despite the ban, The Gambia has some of the world's highest rates of FGM, with at least 73 per cent of women and girls undergoing the procedure, most of them before the age of six, according to the World Health Organization (WHO). Experts say there has been an increase in young infants being subjected to FGM as parents attempt to evade prosecution. Last year, a bill seeking to repeal The Gambia's 2015 FGM ban, introduced by MP Almameh Gibba and supported by some religious leaders, passed its second reading but was ultimately rejected in parliament after intense lobbying from human rights campaigners. Mr Gibba had argued the ban violated citizens' rights to 'practice their culture and religion' in the majority Muslim country. Ms Ali, who is herself a survivor of FGM, said the child's death indicates not enough has been done to enforce the ban, however. 'Just last year, we stood with women in The Gambia to defend the ban on FGM, yet pro-FGM groups, flush with money and organisation, are still winning,' she said. It comes as the UK government has significantly reduced foreign aid spending on programmes related to sexual and reproductive health and rights, including initiatives aimed at ending FGM, as part of a wider cut to the overseas aid budget. The allocation was reduced from 0.5 to 0.3 per cent of gross national income in February. Spending on education, gender, and equality programmes in developing countries has been hit hardest – down 42 per cent from £490 million in 2024/25 to £284 million in 2025/26. 'In 2025, we are still forced to beg for adequate funding for grassroots organisations fighting on the frontline,' said Ms Ali. 'Without serious global backing, more girls will die.'


Telegraph
2 hours ago
- Telegraph
Man poisoned himself after taking medical advice from ChatGPT
A man accidentally poisoned himself and spent three weeks in hospital after turning to ChatGPT for health advice. A US medical journal reported that a 60-year-old man developed a rare condition after he removed table salt from his diet and replaced it with sodium bromide. The man 'decided to conduct the personal experiment' after consulting ChatGPT on how to reduce his salt intake, according to a paper in the Annals of Internal Medicine. The experiment led to him developing bromism, a condition that can cause psychosis, hallucinations, anxiety, nausea and skin problems such as acne. The condition was common in the 19th century and early 20th century, when bromine tablets were routinely prescribed as a sedative, for headaches, and to control epilepsy. The tablets were believed to contribute to up to 8pc of psychiatric admissions. Today, the condition is practically unheard of, with sodium bromide commonly used as a pool cleaner. No previous mental health problems According to the medical paper, the man arrived at an emergency department 'expressing concern that his neighbour was poisoning him'. He later attempted to flee the hospital before he was sectioned and placed on a course of anti-psychotic drugs. The man, who had no previous record of mental health problems, spent three weeks in hospital. Doctors later discovered the patient had consulted ChatGPT for advice on cutting salt out of his diet, although they were not able to access his original chat history. They tested ChatGPT to see if it returned a similar result. The bot continued to suggest replacing salt with sodium bromide and 'did not provide a specific health warning'. They said the 'case highlights how the use of artificial intelligence (AI) can potentially contribute to the development of preventable adverse health outcomes'. AI chatbots have long suffered from a problem known as hallucinations, which means they make up facts. They can also provide inaccurate responses to health questions, sometimes based on the reams of information harvested from the internet. Last year, a Google chatbot suggested users should 'eat rocks' to stay healthy. The comments appeared to be based on satirical comments gathered from Reddit and the website The Onion. OpenAI said last week that a new update to its ChatGPT bot, GPT5, was able to provide more accurate responses to health questions. The Silicon Valley business said it had tested its new tool using a series of 5,000 health questions designed to simulate common conversations with doctors. A spokesman for OpenAI said: 'You should not rely on output from our services as a sole source of truth or factual information, or as a substitute for professional advice.'